MEAGAN ANGERMEIER: Open Payments
NPI 1730715236 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$806 in 38 payments from 11 companies in 2025. Trend: 2023 $853 · 2024 $506 · 2025 $806
Food & beverage: $761Education: $45
| Company | Payments | Amount |
|---|---|---|
| SHIELD THERAPEUTICS INC | 6 | $166 |
| MAYNE PHARMA COMMERCIAL LLC | 10 | $154 |
| Biogen, Inc. | 5 | $122 |
| MILLICENT US INC | 3 | $82 |
| Sumitomo Pharma America, Inc. | 3 | $68 |
| Astellas Pharma US Inc | 3 | $61 |
| Exeltis, USA Inc. | 3 | $49 |
| Hologic Sales and Service, LLC | 1 | $31 |
| Organon LLC | 2 | $30 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
Products named: ACCRUFER, ZURZUVAE, MYFEMBREE, Veozah, SLYND, Sonata Sonography-Guided Transcervical Fibroid Ablation System, NEXPLANON, Exparel.
Industry payments across KS — which companies pay providers there.
